This year we completed (Phase 1) ​the first half of our first ever 4H Leukodystrophy Collaboration Network-prioritized research initiative, focused on disease model and gene therapy development. The project, which teamed up one of the world’s foremost 4HL experts with the President of the American Society of Gene and Cell Therapy, met its objectives and we are looking forward to publication of our findings in the coming months.